Exane Derivatives’s Exelon EXC Stock Holding History

Exane Derivatives’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$158K	Sell	3,486 -1,267	-27%	-$59.6K	0.09%	198
2022 Q1	$226K	Sell	4,753 -5,288	-53%	-$224K	0.06%	299
2021 Q4	$414K	Sell	10,041 -8,210	-45%	-$309K	0.1%	206
2021 Q3	$629K	Buy	18,251 +8,844	+94%	+$302K	0.15%	144
2021 Q2	$301K	Buy	9,407 +7,495	+392%	+$241K	0.07%	290
2021 Q1	$59.7K	Buy	1,912 +276	+17%	+$8.29K	0.02%	501
2020 Q4	$49.3K	Buy	1,636 +676	+70%	+$19.9K	0.01%	457
2020 Q3	$24.5K	Buy	+960	New	+$25.5K	0.01%	418
2019 Q3	–	Sell	-1	Closed	-$48	–	668
2019 Q2	$48	Hold	1	–	–	﹤0.01%	649
2019 Q1	$50	Sell	1 -1,238	-100%	-$42.2K	﹤0.01%	596
2018 Q4	$39.9K	Hold	1,239	–	–	0.01%	376
2018 Q3	$38.4K	Buy	1,239 +151	+14%	+$4.65K	0.01%	381
2018 Q2	$33K	Sell	1,088 -81	-7%	-$2.32K	0.01%	404
2018 Q1	$32.1K	Buy	1,169 +893	+324%	+$24.1K	0.01%	375
2017 Q4	$7.77K	Sell	276 -87	-24%	-$2.5K	﹤0.01%	415
2017 Q3	$9.76K	Sell	363 -11	-3%	-$294	﹤0.01%	394
2017 Q2	$9.63K	Sell	374 -727	-66%	-$18.5K	﹤0.01%	393
2017 Q1	$28.2K	Buy	+1,101	New	+$28.1K	0.01%	310

Other funds holding EXC

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exane Derivatives's EXC Position: Q2 2022 in Review

Exane Derivatives reduced its Exelon (EXC) stake by 27% in Q2 2022, selling an estimated $59.6K and leaving 3,486 shares worth $158K. The position accounts for 0.09% of the portfolio, ranked #198.

Exane Derivatives first reported a position in EXC in Q1 2017 and has held it in 18 quarters since. The position peaked at $629K in Q3 2021. 1,019 funds tracked by Wall St. Rank hold EXC as of Q2 2022.

Exane Derivatives held 3,486 shares of Exelon worth $158K as of Q2 2022.
Exane Derivatives sold 1,267 Exelon shares in Q2 2022, an estimated $59.6K.
Exelon made up 0.09% of Exane Derivatives's portfolio in Q2 2022, its #198 holding.
Exane Derivatives first reported a position in Exelon in Q1 2017 and has held it in 18 quarters since.
Exane Derivatives's Exelon position peaked at $629K in Q3 2021.
1,019 funds tracked by Wall St. Rank held Exelon as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.